Cardiac sarcoidosis: new insights beyond the granuloma using spatial proteomics
Open Access
- 23 December 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (24) , 3174-3188
Abstract
Background and Aims: Cardiac sarcoidosis (CS) is poorly understood, challenging to diagnose, and portends a poor prognosis. A lack of animal models necessitates the use of residual human samples to study sarcoidosis, which in turn necessitates the use of analytical tools compatible with archival, fixed tissue. This study employed high-plex spatial protein analysis to characterize the immunologic, fibrotic, and metabolic landscape of CS. Methods: Cardiac tissues from 64 patients—39 with CS and 25 without CS (Controls)—were analysed using the GeoMx Digital Spatial Profiler. Regions of interest (ROIs) with and without granulomatous inflammation were selected to examine protein abundance. ROIs were further divided into areas of illumination to separately analyse distinct protein profiles in myocytes, stroma, and vessels. A 79-protein panel was used to characterize immune and parenchymal cell populations. Differential protein abundance was evaluated using mixed-effects modeling. A predictive model was developed using a subset of seven proteins to distinguish inflammation-free CS ROIs from control ROIs. Results: Spatial profiling demonstrated marked heterogeneity within and between sarcoidosis granulomas. Inflammation-free ROIs from CS hearts exhibited a ‘distance gradient’, with protein abundance varying by proximity to granulomatous inflammation. The seven-protein predictive model achieved 95.9% accuracy and an area under the receiver operating characteristic curve of 0.993 in differentiating inflammation-free CS ROIs from Controls. Conclusions: Spatial proteomics revealed novel features of the CS microenvironment and identified a distinct immune signature in tissue lacking overt inflammation. These findings may improve diagnostic accuracy in clinical biopsies from patients with suspected CS.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL15807101A1)
- National Heart, Lung, and Blood Institute (K08HL159344)
- Foundation for Sarcoidosis Research
- Bogle Family Foundation
This publication has 52 references indexed in Scilit:
- Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosisClinical and Translational Medicine, 2022
- Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art ReviewJournal of Cardiac Failure, 2021
- How cardiomyocytes sense pathophysiological stresses for cardiac remodelingCellular and Molecular Life Sciences, 2016
- Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist deviceCardiovascular Pathology, 2014
- Increased CD127 expression on activated FOXP3+CD4+ regulatory T cellsEuropean Journal of Immunology, 2010
- Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in ratCell and tissue research, 2008
- Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditisCardiovascular Research, 2005
- Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysisEuropean Journal of Immunology, 2003
- Decreased p38 MAPK Activity in End-Stage Failing Human Myocardium: p38 MAPK α is the Predominant Isoform Expressed in Human HeartJournal of Molecular and Cellular Cardiology, 2001
- Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditisJACC, 1990